Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice  by Hufbauer, M. et al.
Virology 403 (2010) 128–136
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roEnhanced human papillomavirus type 8 oncogene expression levels are crucial for
skin tumorigenesis in transgenic mice
M. Hufbauer a,⁎, D. Lazić a, B. Akgül a, J.L. Brandsma b, H. Pﬁster a, S.J. Weissenborn a
a Institute of Virology, University of Cologne, Cologne, Germany
b Section of Comparative Medicine and Department of Pathology, Yale University School of Medicine, New Haven, CT, USAAbbreviations: EV, epidermodysplasia verruciformis
SCC, squamous cell carcinoma; UV, ultraviolet.
⁎ Corresponding author. Institute of Virology, Univer
Str. 56, 50935 Köln, Germany. Fax: +49 221 4783911/0
E-mail address: Martin@Hufbauer.de (M. Hufbauer)
0042-6822/$ – see front matter © 2010 Elsevier Inc. A
doi:10.1016/j.virol.2010.04.013a b s t r a c ta r t i c l e i n f oArticle history:
Received 22 December 2009
Returned to author for revision 1 March 2010
Accepted 14 April 2010






Skin woundsHuman papillomavirus 8 (HPV8) is involved in skin cancer development in epidermodysplasia verruciformis
patients. Transgenic mice expressing HPV8 early genes (HPV8-CER) developed papillomas, dysplasias and
squamous cell carcinomas. UVA/B-irradiation and mechanical wounding of HPV8-CER mouse skin led to
prompt papilloma induction in about 3 weeks. The aim of this study was to analyze the kinetics and level of
transgene expression in response to skin irritations. Transgene expression was already enhanced 1 to 2 days
after UVA/B-irradiation or tape-stripping and maintained during papilloma development. The enhanced
transgene expression could be assigned to UVB and not to UVA. Papilloma development was thus always
paralleled by an increased transgene expression irrespective of the type of skin irritation. A knock-down of
E6 mRNA by tattooing HPV8-E6-speciﬁc siRNA led to a delay and a lower incidence of papilloma
development. This indicates that the early increase of viral oncogene expression is crucial for induction of
papillomatosis.; HPV, human papillomavirus;
sity of Cologne, Fürst-Pückler-
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Nonmelanoma skin cancer (NMSC), which includes basal cell
carcinoma, squamous cell carcinoma (SCC) and Bowen's disease is the
most common cancer in fair-skinned populations (30% of all cancers)
(Alam and Ratner, 2001; DePinho, 2000; Pﬁster, 2003). As UV
radiation is the main risk factor, NMSC emerges primarily on sun-
exposed skin areas (Leiter and Garbe, 2008). A linkage between
human papillomaviruses (HPV) and the development of human skin
cancer is accepted for the rare inherited disorder epidermodysplasia
verruciformis (EV) and the so called EV-HPV, today phylogenetically
grouped as beta-HPV (de Villiers et al., 2004; Majewski et al., 1997;
Pﬁster and Ter Schegget, 1997). The clinical picture of EV is
distinguished by a life-long occurrence of multiple ﬂat warts and
macular lesions with a high risk of developing SCC later in life
(Jablonska and Majewski, 1994; Orth, 2006). About 14 different HPV
types have been found in benign tumors of EV-patients (Pﬁster,
2003), but only a few virus types were found in cancers, mainly HPV5
or HPV8, which are therefore considered high-risk types. The same
HPV types have been found in actinic keratoses (AK), which are
regarded as SCC precursors (Harwood and Proby, 2002; Pﬁster, 2003).Seroepidemiology supports this correlation, and antibodies against
the major HPV8 capsid protein are associated with both cutaneous
SCC (Feltkamp et al., 2003; Masini et al., 2003) and precancerous AK
(Bouwes Bavinck et al., 2000). Furthermore, the early genes E2, E6 and
E7 of HPV8 have been associated with cellular transformation in vitro
(Akgül et al., 2006, 2007). Together these ﬁndings support the idea
that EV-HPV types contribute to AK and SCC development in the
general population. Infections with beta-HPVs are acquired early in
infancy and most people probably carry persistent infections with
multiple types (Antonsson et al., 2003; Weissenborn et al., 2009a). In
the general population the DNA loads of these HPV types are very low
in the skin and in hair bulbs, which represent their probable reservoir
(Pﬁster, 2003; Weissenborn et al., 2009b). EV patients have a strongly
enhanced risk for the development of SCC, which may be related to
high viral DNA loads, which in turn may result in high oncogene
expression levels (Dell'Oste et al., 2009). Different transgenic mouse
lineages expressing all early genes of HPV8 (E1/E2/E4/E6/E7, HPV8-
CER) (Schaper et al., 2005) or only E2 (Pfefferle et al., 2008) were
recently established at our institute. All transgenes are expressed
under the control of the human keratin-14 (hK14) promoter, which
directs the expression of the transgenes to the stratum basale of the
skin, the hair follicle and to a lesser extent to the stratum spinosum.
HPV8-CER and -E2 mice spontaneously develop papillomas, dyspla-
sias and in 2% (HPV8-E2) or 6% (HPV8-CER) SCC. UVA/B-irradiation
led to a synchronized induction of papilloma development in about
3 weeks (Marcuzzi et al., 2009; Pfefferle et al., 2008). To study a
possible role of viral oncogenes in this rapid tumor development, we
129M. Hufbauer et al. / Virology 403 (2010) 128–136analyzed the kinetics and levels of oncogene expression in these HPV8
mouse lineages following different skin irritations.Results
Enhanced transgene mRNA expression is induced early after
UVA/B-irradiation in HPV8-CER mice
In this study we aimed to determine the impact of HPV8 early gene
expression levels on cutaneous papilloma formation in mice. By
comparative analyses we found that the levels of hK14-promoter
driven transgene expression in HPV8-CER mice were highly correlat-
ed with the mK14 mRNA levels after skin irritation (R=0.85; pb0.01;
shown for mK14 and HPV8-E6 in Fig. 1). We therefore chose mK14
expression to compare the response of keratinocytes of FVB/N wt and
transgenic mice to skin irritation. In further experiments we
ascertained, that neither wounding nor UVA/B-irradiation affected
mK14 expression in adjacent skin areas (data not shown).
The kinetics of mK14 expression were examined over a 30-day
period in UVA/B-irradiated HPV8-CER and FVB/N wt mice (Fig. 1). As
reported in Marcuzzi et al. (2009) the mRNA levels of the housekeep-
ing genes hypoxanthine phosphoribosyltransferase and β-actin
increase after UVA/B-irradiation. This effect did also occur in our
experiments and therefore mRNA levels were normalized to the total
RNA input of one microgram in all qRT-PCR experiments. Generally,
we observed stronger mean levels of mK14 mRNA in HPV8-CER mice
than FVB/Nwtmice. Induction ofmK14 aswell as HPV8-E6 expression
was already seen 1 day after UVA/B-irradiation in HPV8-CER mice. At
all time points between day 2 and day 12 after UVA/B-irradiation
enhanced mK14 expression was measured in both mouse strains. In
FVB/N wt mice mK14 expression returned to almost basal level along
with healing of the irradiated skin. In contrast, mK14 expression as
well as HPV8-E6 expression persisted at a high level in HPV8-CERmice
at all following time points paralleled by papilloma growth.Fig. 1. Enhanced HPV8-E6 and mK14 expression was induced early after UVA/B-
irradiation in HPV8-CER mice. Skin areas (4 cm2) of shaved HPV8-CER and FVB/N wt
mice were UVA/B-irradiated. Skin samples were taken at different time points from
irradiated and non-irradiated areas of skin. MK14 and HPV8-E6 mRNA levels were
measured in 1 μg total RNA via qRT-PCR. The mean expression ratio of mK14 in HPV8-
CER mice (black solid lines), mK14 in FVB/N wt mice (gray lines) and HPV8-E6 in
HPV8-CER mice (black dashed lines) is plotted against time. Error bars represent the
standard deviation. The number of analyzed samples per point in time from different
mice is given in the table below the graph.Oncogene expression levels correlated with papilloma development in
UVA/B-irradiated HPV8-E2 mice
Only a fraction of HPV8-E2mice showed papillomatosis after UVA/
B-irradiation (Pfefferle et al., 2008). To test whether papilloma
formation correlates with different oncogene expression level we
examined skin samples from three E2 mice taken 12 days after UVA/
B-irradiation. The HPV8-E2 mouse, which developed papillomas
showed a 7.5-fold enhanced E2 mRNA expression level. The two
othermice did not develop papillomas and in these animals the HPV8-
E2 expression levels were only 4.1- and 4.7-fold increased.
HPV8-E2 protein expression is increased in HPV8-CER mice soon after
UVA/B-irradiation
To study whether the increase of transgene mRNA expression in
the skin of HPV8-CER mice is mirrored at the protein level and to
characterize the HPV8-oncoprotein positive epidermal layers, immu-
nohistochemical HPV8-E2 staining experiments of UVA/B-irradiated
and non-irradiated HPV8-CER skin sections were performed. Untreat-
ed HPV8-CER skin revealed a clear but faint HPV8-E2 signal in the
epidermis (Fig. 2) whereas in line with RNA data, HPV8 transgene
protein expression increased already 1 day after UVA/B-irradiation in
the epidermis. Enhanced number of transgene expressing cells
emerging from an increased number of epidermal cell layers and a
more intense staining were observed. The enhanced HPV8-E2 protein
expression was maintained over the whole observation period ending
on day 24 after UVA/B-irradiation, when a papilloma with multiple
epidermal cell layers and horn pearls had already developed.
Keratinocytes of FVB/N wt skin were not stained by the anti-HPV8-
E2 serum, proving the speciﬁcity of the antibody (Fig. 2, FVB/N
10 days and 24 days after UV-irradiation). Histology of UVA/B-
irradiated FVB/N wt mouse skin showed an only slightly thinner
epidermis than in HPV8-CERmice until day 7 after UVA/B-irradiation.
However, about 10 days after UVA/B-irradiation, the epidermis of
control FVB/N wt mice started to return to its normal status with one
or two cell layers.
UVB-irradiation alone is sufﬁcient to induce transgene expression in
HPV8-CER mice
It was previously shown by Marcuzzi et al. (2009), that 0.36 J/cm2
UVB-irradiation alonewas sufﬁcient to induce papillomatosis inHPV8-
CER mice, while 10 J/cm2 UVA-irradiation did not lead to papilloma
development. To assess whether these treatments also differ in their
ability to stimulate HPV8 transgene expression, mK14 levels were
measured in UVA- and UVB-irradiated HPV8-CER and FVB/N wt mice.
In contrast to the conﬂuent papillomatosis induced by UVA/B-
irradiation, UVB-irradiation alone induced multiple small papillomas.
Twelve days after UVB-irradiation both FVB/Nwt and HPV8-CERmice
showed an upregulatedmK14 expression (Fig. 3), similarly to the data
presented in Fig. 1. In contrast, after UVA-irradiation,mK14 expression
increased in neither FVB/N wt nor HPV8-CER mice.
Mechanical skin irritation as an inducer of papillomatosis in HPV8-CER
mice
Wounding of HPV8-CER mouse skin by punch biopsy elicits the
development of a conﬂuent mass of papillomas (Marcuzzi et al.,
2009). In this study tape-stripping was chosen as a model for
mechanical skin irritation. Tape-stripping ablates corniﬁed keratino-
cytes (Lademann et al., 2009) and induces multiple small punctate
wounds (Fig. 4, 24 h after treatment). Macroscopically the wounds
appeared to be healed within 10 days. Starting on about day 14,
papillomas began to appear on areas of treated skin, particularly those
with the most severe wounds. These papillomas grew larger over the
Fig. 2. Immunohistochemical staining for HPV8-E2 in HPV8-CER skin sections revealed rapid enhancement of HPV8-E2 protein expression after UVA/B-irradiation. Skin areas
(4 cm2) of shaved HPV8-CER and FVB/Nwtmice were UVA/B-irradiated (10 J/cm2; 1 J/cm2). For each point in time skin samples were taken from twomice from the irradiated skin.
Skin samples were also taken from two non-irradiated HPV8-CER and FVB/N wt mice. After formalin-ﬁxation and parafﬁn embedding, samples were cut into 4 µm sections. HPV8-
CER sections were stained against HPV8-E2 and counterstained with hematoxylin. FVB/N wt UV 10-day and 24-day sections were also incubated with the anti-HPV8-E2 serum and
counterstained with hematoxylin, all other FVB/N wt sections were just stained with H&E. Magniﬁcation: 400×.
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Fig. 2 (continued).
131M. Hufbauer et al. / Virology 403 (2010) 128–136following observation period. Beginning on day 19, additional small
spike-shaped papillomaswere detectable on the treated skin area. The
inﬂuence of mechanical skin irritation on transgene expression wasinvestigated in three tape-stripped HPV8-CER mice. Two days after
tape-stripping, four samples of wounded skin with different grades of
injury were taken from each mouse to quantitate HPV8-E6 mRNA
Fig. 3. UVB-irradiation alone led to enhancedmK14 expression in HPV8-CER and FVB/N
wt mice, while UVA-irradiation did not. Skin areas (4 cm2) of three shaved HPV8-CER
and three shaved FVB/N wt mice were either UVA-irradiated (10 J/cm2) or UVB-
irradiated (0.36 J/cm2). Skin samples were taken 12 days after UVA- or UVB-irradiation
from the irradiated and non-irradiated skin. MK14 mRNA expression levels were
measured in one microgram total RNA via qRT-PCR. Bars represent the mean mK14
expression ratio. Error bars represent the standard deviation.
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injuries and showed enhanced HPV8-E6 expression, while mouse C
had only minor wounds and minimal if any elevation of HPV8-E6
expression. Overall, samples with a macroscopically visible wound
(A1, A2, A3, B1, B2) showed enhanced (1.5- to 2.9-fold) HPV8-E6
expression, while samples with no visible or only tinywounds (A4, B3,
B4, C1, C2, C3, C4) showed normal or slightly enhanced (0.8- to 1.5-
fold) HPV8-E6 expression.Fig. 4. Induction of papilloma growth by mechanical skin irritation. HPV8-CER mice were sh
attaching and detaching 15 times a new piece of tape. Pictures show treated skin areas at dif
starting from day 19 additional small spike-shaped papillomas were detectable on the treaKnock-down of HPV8-E6 during tumor induction inhibits papilloma
development
Wounding of themouse skinwith a tattoomachine can also induce
papilloma development within 2 to 3 weeks (Fig. 6A). This opened up
the possibility to test whether tattooing of HPV8-E6 speciﬁc siRNAs
intoHPV8-CERmouse skin could reduce or even inhibit papillomatosis
by knocking-down HPV8-E6 expression. To characterize the HPV8-E6
knock-downkinetics, RNAwas isolated at different points in time from
HPV8-E6 expressing HaCaT cells transfected with four siRNAs. As
shown in supplementary ﬁgure 1c, HPV8-E6 mRNA was knocked-
down to 10% at 24 h and 30 h post transfection of siRNA-1 duplex. The
HPV8-E6 mRNA levels began to rise again 48 h after transfection. Ten
HPV8-CER mice were tattooed with water or siRNA-1 duplex/
Lipofectamin 2000 on two separate, shaved, and depilated skin areas
each, thereby inducing 40wounds. Images of tattooed skinwere taken
at different points in time. The wounds caused by tattooing water or
siRNA-1 duplex/Lipofectamin 2000 (Fig. 6A) started to heal and the
skin seemed to be restored around day 10 after treatment. On day 18
after treatment, papilloma development started in the water tattooed
areas, while only a small cicatricial spot could be observed in the
siRNA-1 tattooed skin. On day 28, papilloma development was also
visible in some siRNA-1 tattooed areas, but it was remarkably slowed
down and reduced. Overall, papilloma development in skin areas
wounded by tattooing siRNA-1 was delayed by about 10 days when
compared to water treated areas (Fig. 6B). On day 42, about half of the
siRNA-1 tattooed areas still showed no papillomatosis (11 out of 20
wounds), whereas only 5 out of 20 water-tattooed skin areas were
devoid of papillomatosis. The emerged papillomas in the siRNA-1
tattooed area remained small and locally restricted in contrast to the
pronounced papillomas in the water treated areas, which overgrew
the former wound areas (Fig. 6A).aved and treated with depilatory cream on a 4 cm2 sized skin area and then treated by
ferent points in time. A papillomatous area is ﬁrst visible on day 14 after treatment and
ted skin area.
Fig. 5. Severe mechanical skin irritation enhances HPV8-E6 expression early after treatment. Three HPV8-CER mice were shaved and treated with depilatory cream on a 4 cm2 sized
skin area and then treated by attaching and detaching 15 times a new piece of tape. Two days after treatment four skin samples were taken from each mouse as indicated by the
circles in the pictures. Additionally one area of untreated skin was taken from each mouse. HPV8-E6 mRNA expression levels were measured in one microgram total RNA via qRT-
PCR. Bars represent the HPV8-E6 expression ratio of a single skin sample.
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We recently showed the oncogenic potential of HPV8 in the skin of
transgenic mouse lines (Marcuzzi et al., 2009; Pfefferle et al., 2008;
Schaper et al., 2005). However, little is known about the triggers of
tumorous skin growth. In this study, we investigated the kinetics of
HPV8 gene expression in transgenic mouse models in response to
exogenous skin irritations. Furthermore, we investigated the rela-
tionship between increased expression of the viral oncogenes and the
induction of tumor development. It is known that UV-irradiation, the
main risk factor for SCC development (Leiter and Garbe, 2008), can
induce the natural promoters of the HPV5 and 8 oncogenes (Akgül
et al., 2005), as well as the cellular K14 promoter (Kinouchi et al.,
2002). Therefore, we ﬁrst used UVA/B-irradiation to enhance the
hK14-promoter driven viral oncogene expression in HPV8-CER mice.
As expected, the endogenous mK14 promoter was induced in parallel
just as in non-transgenic FVB/N wt mice. HPV8-E6 mRNA levels rose
already 1 day after irradiation and reached a maximum after two to
4 days. High levels of HPV8-E6 and mK14 mRNAs persisted in the
transgenics accompanied by papilloma development. In contrast, in
the FVB/N wt mice, the level of mK14 mRNA gradually returned to
normal when the UVA/B-induced hyperplasia started to resolve.
Immunohistological staining for HPV8-E2 protein in sections from
UVA/B-irradiated HPV8-CER skin conﬁrmed increased transgene
expression already 1 day after induction. In the HPV8-CER mice,
UVB-irradiation alone induced multiple small papillomas whereas
UVA plus UVB elicited conﬂuent papillomas in the whole irradiated
skin area. However, the HPV8 transgene levels in papillomas elicited
by either UVB or UVA/UVB irradiation were similar. In contrast, UVA-
irradiation alone enhanced neither mK14 expression nor papilloma
development. Thus, in our mouse models UVB is the main cause of
enhanced transgene expression and tumor growth. Additional stimuli
may further promote papilloma development, and our data indicate
that UVA has a synergistic effect on UVB-induced papilloma de-velopment (Marcuzzi et al., 2009). This effect is not mediated by
enhancing transgene expression, but possibly by causing oxidative
stress (Burke and Wei, 2009).
Papillomas also developed spontaneously in non-irradiated HPV8-
CER mice, but at lower frequency and slower rates and mostly dorsal
caudal, despite a constitutive transgene expression in the entire
mouse epidermis (Marcuzzi et al., 2009; Pfefferle et al., 2008; Schaper
et al., 2005). Since male mice ﬁght more than female mice, we
speculated that ﬁght wounds might enhance tumor development.
This assumption is supported by the present observation that skin
regeneration processes induced by tape-stripping are sufﬁcient to
induce papilloma development in HPV8-CER mice. In contrast to the
area wide papillomatous growth elicited by UVA/B-irradiation, tape-
stripping elicited only small, discrete papillomas. As the K14-
promoter is known to be activated in hyperplastic skin (Coussens et
al., 1996; Rossiter et al., 2001; Schaper et al., 2005; Sethi and Palefsky,
2004) it was conceivable to ﬁnd enhanced HPV8-E6 expression levels
in tape-stripped skin areas. The E6 expression levels in tape-stripped
skin areas were overall less pronounced than those observed in UVA/
B-irradiated areas. This may point to a smaller number of stimulated
keratinocytes in tape-stripped skin in contrast to UVA/B-irradiated
areas for which the stimulation of the majority of keratinocytes may
be expected with the associated enhanced risk for tumor growth. The
severity of skin wounding by tape-stripping appeared to correlate
with enhanced transgene expression 2 days after treatment and with
the probability of papilloma induction. In concordance with our data
an induction of the viral promoter was also detected in papillomas
of UV-irradiated rabbits latently infected with the cottontail rabbit
papillomavirus, whereas no induction of the viral promoter was
observed in UV-irradiated, papilloma-free, but CRPV-DNA positive
skin (Zhang et al., 1999).
The reduced penetrance of tumor development after the less
efﬁcient induction of transgene expression following abrasive skin
irritations compared to UVA/B-irradiation points to a dose-response
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transgenic mice. Both different basic levels of HPV8-E2 mRNA in three
HPV8-E2 transgenic strains (Pfefferle et al., 2008) and different levels
of UVA/B-induced E2 mRNA (this paper) turned out to inﬂuence
incidence and rate of tumor development. As no papilloma growth
was observed in tape-stripped HPV8-CER mice and UV-irradiated
HPV8-E2 mice with only moderate induction of viral mRNA, a certain
threshold of oncogene expression seems to exist, which has to be
crossed for acute transformation of keratinocytes.
A direct link between elevated viral gene expression and tumor
formation could be demonstrated by siRNA-mediated HPV8-E6mRNA
knock-down, which clearly reduced papilloma development. Residual
papilloma development in siRNA treated animalsmay be explained by
an inconsistent delivery of the siRNA. As demonstrated in cell culture
experiments, the efﬁcient HPV8-E6 knock-down lasted about 4 days
after transfection, with a maximal effect around 30 h after siRNA
transfection. Similar kinetics were reported for siRNAs injected into
mice, where the knock-down decreased after a maximum on day 1 or
2 (Layzer et al., 2004; Nishina et al., 2008). Assuming that the knock-
down also lasts for only a few days in the skin of HPV8-CER mice, the
initial rise of HPV8-E6 expression seems to have a decisive impact on
the early steps in papilloma development. The maintenance of high
levels of oncogene mRNA is likely to be due to the ongoing papilloma
growth.
The enhanced expression of viral oncogenes after irritation of
mouse skin may mirror the conversion of a latent beta-HPV infection
into an activated infection in man following sunburn or immunosup-
pression. The crucial importance of a shortly enhanced viral oncogene
expression over a certain threshold for the initiation of tumor growth
in HPV8 transgenic mice may indicate that such a transient induction
of the viral promoter also elevates the risk for tumor development in
man. Cellular processes affected by solar exposure or wounding will
certainly be relevant for perpetuation and progression of lesions
together with ongoing viral activities.
Methods
Mice, skin irritation and sample collection
Mice used here include transgenic hemizygous mouse lineages
either expressing all early genes of HPV8 (E1/E2/E4/E6/E7, HPV8-
CER) or -E2 separately under the control of the hK14 promoter,
backcrossed into the FVB/N background and FVB/N wild-type (wt)
mice (Pfefferle et al., 2008; Schaper et al., 2005). Mice were
anesthetized with ketamine-hydrochloride (Sigma, Deisenhofen,
Germany) and xylazine-hydrochloride (Sigma, Deisenhofen,
Germany) and shaved with an electric shaver (Wella, Karlsruhe,
Germany) before dorsal caudal skin irritation at an age of 6–12 weeks.
For UV-experiments HPV8-CER and FVB/N wt mice were either
irradiated with 10 J/cm2 UVA and 1 J/cm2 UVB or with 10 J/cm2 UVA
alone or 036 J/cm2 UVB alone on a 4 cm2 sized area as reported before
(Marcuzzi et al., 2009; Pfefferle et al., 2008). Treated skin areas were
macroscopically observed daily and skin samples for RNA analysis
were removed fromanesthetized or euthanizedmicewith a 4 mmskin
punch biopsy tool (PFM, Cologne, Germany) 6 hours, 1 days, 2 days,
4 days, 7 days, 12 days, 18 days, 24 days or 30 days after UVA/B-
irradiation and 12 days after UVA or UVB-irradiation and stored at
-20 °C in RNALater according to protocol (Qiagen, Hilden, Germany).
Negative control skin samples were taken from untreated skin at theFig. 6. Tattooing HPV8-E6 speciﬁc siRNA slowed down papillomatosis in HPV8-CER mice. T
(siRNA-1 duplex/Lipofectamin 2000) were tattooed into two separate areas of the mouse sk
(A) Tattooed skin areas of four mice on days 1 and 42 after tattooing. (B) Kaplan–Meier curve
tattooed HPV8-CER skin areas plotted against time.end of the respective observation interval. For immunohistochemical
experiments skin samples were collected 0 days, 1 days, 2 days,
3 days, 5 days, 7 days, 10 days and 24 days after UVA/B-irradiation
from HPV8-CER and FVB/N wt mice, formalin-ﬁxed and embedded in
parafﬁn. For tape-stripping experiments HPV8-CERmice were treated
with depilatory cream (Balea, Karlsruhe, Germany) on a 4 cm2 sized
area after shaving. These mice were further treated by attaching and
detaching 15 times a new piece of tape (Tesa, Hamburg, Germany) in
the depilated skin. Four samples of the irritated skin and one sample of
non-irritated skin from eachmouse were taken 2 days after treatment
and stored at -20 °C in RNALater (Qiagen). Tattooing was performed
using a “Rotary 12000PL” tattoo machine with 5-Liner needles
(Bortech, Wuppertal, Germany) run by 17.5 V (DC POWER SUPPLY,
DF 1730 SB3A, Bortech, Wuppertal, Germany) thereby inducing 725
pinholes per second. Tenmicroliter transfection-mix, composed of 1 µl
siRNA-1 duplex (100 µM), 1 µl Lipofectamin 2000 (Invitrogen,
Karlsruhe, Germany) and 8 µl water or 10 µl water alone were
delivered to a dorsal area of shaved and depilated HPV8-CER mouse
skin followed by tattooing a skin stripe of 1 cm length three times for
5 s each. The tattoo machine was adjusted to allow the tattoo needles
to penetrate the skin 1-2 mm. The siRNA used in this study was
designed andmanufactured by Qiagen (Hilden, Germany) and had the
following sequence: siRNA-1 sense: CCGCAACGUUUGAAUUUAAdTdT,
siRNA-1 antisense: UUAAAUUCAAACGUUGCGGdTdT.
RNA isolation and reverse transcription
RNA from skin samples was isolated with RNeasy kit and DNase
digestion was performed on column using RNase-free DNase accord-
ing to the manufacturer's instructions (Qiagen, Hilden, Germany).
One microgram of RNA was reverse transcribed using Omniscript kit
(Qiagen, Hilden, Germany) with 1 µM oligo-dT23-primer (Sigma,
Deisenhofen, Germany), 10 µM Random Nonamers (TIB MOLBIOL,
Berlin, Germany) and 10 units RNase Inhibitor (Fermentas, St. Leon-
Rot, Germany).
Real-time-PCR
Murine K14 (mK14) and transgene levels were measured by real-
time PCR (qRT-PCR) using the LightCycler System (Roche, Mannheim,
Germany). Two microlitres of a 1:10 dilution of cDNA were used in a
total volume of 20 µl containing 1.25 units Platinum Taq Polymerase
and the associated buffer (Invitrogen, Karlsruhe, Germany), 4 mM
MgCl2, 1.6 µl of a 1:1000 dilution of SybrGreen (Sigma, Deisenhofen,
Germany), 5% DMSO, 0.5 µM forward and backward primer each,
500 ng/µl non-acetylated bovine serum albumin (Fermentas, St.
Leon-Rot, Germany) and 0.2 mM dNTP each. Samples were analyzed
in duplicate together with a cDNA dilution series, which was used to
generate a standard curve. Mean values were used for the calculation
of expression ratios from untreated to treated skin using Pfafﬂ's
equation (Pfafﬂ, 2001). RNA levels were normalized to the RNA input
of one microgram. The cycling protocol conditions were 60 s at 95 °C,
followed by 40 cycles of 1 s at 95 °C (20 °C/s), 5 s at Tann. (20 °C/s),
and 15 s at 72 °C (20 °C/s). Fluorescence wasmeasured once per cycle
at the end of the elongation step. The primers used in this study had
the following sequences, mK14fw: 5′-tccagagatgtgacctcc-3′,
mK14bw: 5′-ccaccttgccatcgt-3′, HPV8E6fw: 5′-gcaacgtttgaattta-3′,
HPV8E6rev: 5′-catgatacaaatgcttac-3′. Primers for HPV8-E2 were
taken from Schaper et al. (2005).en HPV8-CER mice were shaved and depilated. Ten microliter each of transfection-mix
in. As control 10 µl water were tattooed into two separate skin areas of the same mouse
s show the percentage of papilloma development in 20 water-tattooed and 20 siRNA-1-
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Deparafﬁnization of 4 µm thick tissue sections was done by
incubation in xylene two times for 5 min. Samples were hydrated
through a descending alcohol series (100%, 90%, 70%; 5 min each) and
endogenous peroxidases were inactivated by incubation in 3% H2O2 in
methanol for 10 min. Antigen unmasking was performed by boiling
the tissue sections in 10 mM citric buffer in a pressure cooker for
4 min in a microwave. Further incubation steps were performed in a
humid chamber to prevent drying-out. After blocking unspeciﬁc
antigen sites with PBS/20% FCS for 1 h, samples were incubated with a
primary guinea pig antibody against HPV8-E2 in PBS/2% FCS for
90 min followed by three washes with PBS. The antibody was raised
against a 6x-His-tagged HPV8-E2 protein, generated in bacteria and
puriﬁed on a nickel column. Incubation with a secondary antibody
(anti-guinea pig conjugated with horseradish peroxidase) diluted in
PBS/2% FCS was done for 1 h. Following three washes with PBS DAB
staining was performed with the Liquid DAB Concentrated Substrate
Pack (BioGenex, San Ramon, USA). Sections were counterstained with
hematoxylin and dehydrated with an ascending alcohol series and
embedded with mounting medium.
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